Concurrent TTFields (200 kHz) with chemoradiation for patients with newly diagnosed glioblastoma may increase the rate of pseudoprogression: secondary analysis of a pilot clinical trial
Open Access
- 1 January 2022
- conference paper
- Published by XMLink
- Vol. 10 (Suppl) , S180